Anonymous said:I'll send you a DM
....
Look, Angela Wright, take a look at this. 😢
If you look right here, it states they are currently in Phase 2 clinical trials (there are four stages total, though some consider the first one purely preclinical). It honestly seems like that’s the bottleneck—they haven't reached the stage where they test if this can actually help patients already undergoing "standard" treatment, or how it might interact with existing protocols. It sounds discriminatory, almost idiotic, considering there's nothing left to lose when you're fighting glioblastoma, but that's how these protocols work. At the end of the day, there is massive money moving through these channels, and plenty of powerful people have skin in the game.